ArticleBritish journal of cancer2016

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.

Brittney S Harrington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.